LadRx (NASDAQ:CYTR) Research Coverage Started at StockNews.com
LadRx (NASDAQ:CYTR) Research Coverage Started at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of LadRx (NASDAQ:CYTR – Get Rating) in a research note issued on Sunday. The firm set a "hold" rating on the stock.
StockNews.com的股票分析师假设对以下股票进行了报道 LadRx（纳斯达克股票代码：CYTR — 获取评级） 在周日发布的研究报告中。该公司对该股设定了 “持有” 评级。
LadRx Price Performance
LadRx 价格表现
LadRx has a 1 year low of $0.05 and a 1 year high of $0.86. The stock has a fifty day moving average of $0.09.
LadRx创下1年低点0.05美元，1年高点为0.86美元。该股的五十天移动平均线为0.09美元。
About LadRx
关于 LadRx
(Get Rating)
（获取评分）
LadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor.
LadRx Corp. 是一家生物制药研发公司，从事新型抗癌候选药物的发现、研究和临床开发。它专注于开发Linker Activated Drue Release（LADR）技术平台，该平台是一个发现引擎，可帮助创建抗癌分子管道，避免不可接受的全身毒性，同时将高效药物直接输送到肿瘤。
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on LadRx (CYTR)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
- 免费获取 StockNews.com 关于 LadrX (CYTR) 的研究报告
- MarketBeat Week 回顾 — 2 月 27 日 — 3 月 3 日
- 升级幅度最高的三只股票正在逆转
- 如何找到蓝筹股股息股
- Zscaler, Inc. 暴跌，是时候逢低买入了吗？
- 什么是良好的股息收益率？如何决定
Receive News & Ratings for LadRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LadRx and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收 LadRx 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收LadrX及相关公司的最新新闻和分析师评级的简明每日摘要。